CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

/C O R R E C T I O N -- InstaMed® Pharmaceuticals/

Non-Injectable Peptide PlatformPositive
AI Analysis

Summary

InstaMed Pharmaceuticals appoints Tracy Gibbs, PhD as Chief Executive Officer ahead of the worldwide launch of its non-injectable peptide platform technology.

Importance:3/10
Sentiment:
0.30
management_changeceo_appointmentpeptide_platformcommercial_stage

Read the original article

Published by PR Newswire Clinical Trials on July 29, 2026 11:29 PM

Read Original